Position in XAIR
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11
-$9,190 QoQ
Shares Held
1
-97.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 28 holders
Holding Since
Dec 2021
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in XAIR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026FMR LLC holds $9,354,933,608 across 97 Medical Devices names. XAIR ranks #97 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BSX |
Boston Scientific Corp
|
45,702,845 | $1,950,597,421 | |
| 2 | BRKR |
Bruker Corp
|
20,683,975 | $1,417,902,444 | |
| 3 | ABT |
Abbott Laboratories
|
13,423,080 | $1,218,010,276 | |
| 4 | EW |
Edwards Lifesciences Corp
|
8,435,949 | $763,115,943 | |
| 5 | TXG |
10x Genomics, Inc.
|
17,629,266 | $675,906,056 | |
| 6 | SYK |
Stryker Corp
|
1,702,373 | $535,975,113 | |
| 7 | TMDX |
TransMedics Group, Inc.
|
5,133,328 | $340,955,642 | |
| 8 | NVCR |
NovoCure Ltd
|
17,373,078 | $263,202,131 |
All Filings in XAIR
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11 | 25 | Shares | Defined | 2026-08-13 | |
| 2024-06-30 | $9,201 | 17,135 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $14,374 | 8,261 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $21,585 | 11,013 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $55,123 | 23,863 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $6,479 | 1,521 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $5,163 | 765 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $2,031 | 313 | Shares | Defined | 2023-02-13 | |
| 2022-03-31 | $133 | 20 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $311 | 33 | Shares | Defined | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||